Prognostic factors for multiple myeloma in the era of novel agents.
Bladé
J
J
Institut of Hematology and Oncology, Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain.
Rosiñol
L
L
Cibeira
M T
MT
D006801:Humans; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis